These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Quantitative bone histomorphometry and circulating T lymphocyte subsets in postmenopausal osteoporosis. Imai Y, Tsunenari T, Fukase M, Fujita T. J Bone Miner Res; 1990 Apr; 5(4):393-9. PubMed ID: 2343779 [Abstract] [Full Text] [Related]
27. Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis. Ste-Marie LG, Sod E, Johnson T, Chines A. Calcif Tissue Int; 2004 Dec; 75(6):469-76. PubMed ID: 15478000 [Abstract] [Full Text] [Related]
29. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis. Ribom EL, Ljunggren O, Mallmin H. J Clin Densitom; 2008 Dec; 11(3):404-11. PubMed ID: 18280191 [Abstract] [Full Text] [Related]
31. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats. Cui L, Wu T, Liu YY, Deng YF, Ai CM, Chen HQ. Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837 [Abstract] [Full Text] [Related]
39. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience. Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U. J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620 [Abstract] [Full Text] [Related]